Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Annales D'Endocrinologie|March 18, 2020
Monitoring patients receiving dopamine agonist therapy for hyperprolactinaemiaC E Stiles, R P Steeds, W M DrakeJournal of Biomedical Materials Research|July 25, 2000
Tissue response to single-polymer fibers of varying diameters: evaluation of fibrous encapsulation and macrophage densityJ E Sanders, C E Stiles, C L HayesEndocrinology, Diabetes & Metabolism Case Reports|March 27, 2018
<i>De novo</i> HNF1 homeobox B mutation as a cause for chronic, treatment-resistant hypomagnesaemiaC E Stiles, R Thuraisingham, D Bockenhauer, et al.The Journal of Clinical Endocrinology and Metabolism|September 15, 2018
A meta-analysis of the prevalence of cardiac valvulopathy in hyperprolactinemic patients treated with CabergolineC E Stiles, E T Tetteh-Wayoe, J Bestwick, et al.The Journal of Clinical Endocrinology and Metabolism|November 5, 2013
A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonistsW M Drake, C E Stiles, T A Howlett, et al.Pageof 1